---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-24-000018"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T22:18:08.561337+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# ICU Medical holds 2024 Annual Meeting; all director nominees elected, auditor ratified, say-on-pay approved

## Summary
- All seven director nominees elected: Vivek Jain, David C. Greenberg, Elisha W. Finney, David F. Hoffmeister, Donald M. Abbey, Laurie Hernandez, Kolleen T. Kennedy.
- Ratification of Deloitte & Touche as independent auditor for FY 2024 approved with 22,484,283 votes for, 222,466 against.
- Advisory vote on named executive officer compensation approved with 20,673,543 votes for, 824,221 against.
- Broker non-votes totaled 1,202,538 on director election and say-on-pay proposals.

## SEC filing metadata
- accession: 0000883984-24-000018
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398424000018/0000883984-24-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398424000018/icui-20240515.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-24-000018
- JSON: https://secwatch.observer/filing/0000883984-24-000018.json
- Plain text: https://secwatch.observer/filing/0000883984-24-000018.txt

## Source-grounded claims
- claim_id: 7cdf88d57904472ab6e38a96027464f9d1554c74
  claim: ICU MEDICAL INC/DE shareholders approved Election of directors at the 2024-05-15 meeting.
  evidence_excerpt: The Company’s stockholders elected each of the director nominees to serve as a director until the next annual meeting of stockholders or until their respective successor is elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883984/000088398424000018/0000883984-24-000018-index.htm
- claim_id: a63ac92ef9b77a7cb459fe12b08c14dbbe816063
  claim: ICU MEDICAL INC/DE shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-15 meeting.
  evidence_excerpt: The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883984/000088398424000018/0000883984-24-000018-index.htm
- claim_id: ceace878356555685341204ca62af4217cd0118d
  claim: ICU MEDICAL INC/DE shareholders approved Approve the advisory vote on the Company’s named executive officer compensation at the 2024-05-15 meeting.
  evidence_excerpt: The Company’s stockholders approved, on an advisory basis, the Company’s named executive officer compensation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883984/000088398424000018/0000883984-24-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.